换一批Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials.
第一作者：
M,Monami
第一单位：
Section of Geriatric Cardiology and Medicine, Careggi Teaching Hospital, Florence, Italy. mmonami@libero.it
作者：
医学主题词
血压(Blood Pressure);糖尿病, 2型(Diabetes Mellitus, Type 2);糖尿病血管病变(Diabetic Angiopathies);二肽基肽酶Ⅳ抑制剂(Dipeptidyl-Peptidase IV Inhibitors);女(雌)性(Female);人类(Humans);发病率(Incidence);脂类代谢(Lipid Metabolism);男(雄)性(Male);心肌梗死(Myocardial Infarction);随机对照试验(主题)(Randomized Controlled Trials as Topic);危险因素(Risk Factors);卒中(Stroke)
DOI
10.1111/dom.12000
PMID
22925682
发布时间
2024-12-19
- 浏览11
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
